• 제목/요약/키워드: Breast malignancy

검색결과 178건 처리시간 0.024초

구강 편평세포암에서 EGFR과 C-erb-B2 유전자 발현에 관한 면역조직화학적 연구 (IMMUNOHISTOCHEMICAL ANALYSIS OF EGFR AND C-ERB-B2 GENE EXPRESSION OF SQUAMOUS CELL CARCINOMA IN ORAL CAVITY)

  • 조원;조재식;이종원;김해송;박근재
    • 대한기관식도과학회지
    • /
    • 제2권2호
    • /
    • pp.200-212
    • /
    • 1996
  • The clinical staging systems for oral squamous cell carcinoma is limited as a prognostic indicatior because of different biological characteristics of cancer in this region and variable microenvironment depending on subsites, there have been study to determine prognosis by evaluating malignancy, that is the nature of tumor cells. Many studies have been tried to determine prognostic indicator in various malignancies for the evaluation of differentiation capacity and the expression of oncogene product. EGF make a role in cellular growth and differentiation and to be essential in cellular survival. EGFR is an intergral membrane protein, stimulate cellular differentiation and hormonal secretion, and has structural homology with V-erb-B transforming protein. Recent reports have demonstrated that EGFR is overexpressed in stomach, breast, vagina, dermis, head and neck, genitourinary and lung tumors, and possibly used as a tumor marker. In head and neck region, most of studies were mainly carried out on laryngeal squamous cell carcinoma. In the present study, immunohistochemical study for EGFR and C-erb-B2 gene in paraffin sections of 45 squamous cell carcinoma in oral cavity was performed to evaluate the presense of EGFR and C- erb-B2 gene in this lesion, to evaluate them as a prognostic indicator by analysing the correlation between these expression and subsites, primary stages, clinical stages, pathologic grades, neck node metastasis, recurrences and treatment results, and to determine relation between EGFR and C-erb-B2 gene.

  • PDF

흉수 및 복수로 전이된 암종의 세포학적 분석 (Cytologic Analysis of Metastatic Malignant Tumor in Pleural and Ascitic Fluid)

  • 주미;조혜제
    • 대한세포병리학회지
    • /
    • 제6권2호
    • /
    • pp.125-132
    • /
    • 1995
  • Cytodiagnosis of pleural and ascitic fluid is a commonly performed laboratory examination. Especially, positivity for malignant cells in effusion cytology is very effective and also presents the first sign of malignancy in unknown primary site of the tumor. We examined each 34 cases of pleural and ascitic fluid cytologic specimen diagnosed as metastatic tumor, which was selected among 964 pleural fluid cytology cases and 662 ascitic fluid cytology cases from September 1989 to June 1995. Among the pleural fluid cytology specimens examined, 34 specimens were positive in 27 patients. The lung was the most frequent primary site(44%), followed by the stomach (12%), lymphoreticular neoplasm(12%), pancreas(3%) and colon(3%). And the cases of unknown primary site with positive pleural biopsy alone were 24%. Among trio ascitic fluid cytology specimens examined, 34 specimens were positive in 29 patients. The most common primary neoplasms. were carcinomas of ovary(32%), stomach(22%), colon(6%), breast(3%), pancreas(3%), and lung(3%) and lymphoreticular neoplasms(3%) The metastatic tumor was predominantly adenocarcinoma type in both pleural(82%) and ascitic(91%) fluid. The study of metastatic adeno- carcinoma in effusion from lung, ovary, and stomach was undertaken to find distinctive features for the identification of the primary site. The smears of metastatic pulmonary adenocarcinoma had a tendency to show high grade pleomorphism and many large tight cell clusters, whereas that of the ovarian adenocarcinoma showed low grade pleomorphism with abundant intracytoplasmic vacuoles in relatively clear background. That of the stomach revealed the intermediate features.

  • PDF

Prevalence of Types of Cancers in the Elderly Covered by Insurance of the Islamic Republic of Iran Broadcasting Company in 2015 - Comparison with Younger Groups

  • Roshani, Zahra;Kamrani, Ahmad Ali Akbari;Shati, Mohsen;Sahaf, Robab
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권sup3호
    • /
    • pp.269-273
    • /
    • 2016
  • Presently, the world population of the elderly is growing. By improving health hygiene and welfare indicators, mortality and birth rates decrease and life expectancy increases, making the present century the century of elderly. Aging is one of the main risk factors for development of cancer, which itself is the second cause of death in old people. This study was conducted to assess the prevalence of cancer in the elderly covered by the Islamic Republic of Iran Broadcasting (IRIB) insurance program and to obtain suitable programs for cancer screening and early detection, increase patient survival, improve elderly care and to reclaim the cost of treatment in comparison to the national and international statistics. This is a cross-sectional study conducted on all elderly patients diagnosed with malignancy based on their pathology reports. In this study, of the total 75,500 patients covered by IRIB insurance, 17.2% belonged to the elderly group, males accounting for 53.3%. The most common cancers in old men were prostatic cancer (61.3%), colon cancer (10.3%) cancer of the hematologic system, bladder cancer (9.6%), lung cancer (9.1%), thyroid cancer (3.9%) and brain tumors (1.3%). In the elderly women, the most common cancers were breast cancer (80.1%), colon cancer (5.1%), thyroid cancers (4.4%), bladder and hematologic system malignancies (3.6), lung cancer (2.9%) and brain tumors (0.7%). In addition, the prevalence of cancer was almost the same as national and international statistics. With the exception of non-melanoma skin cancer no difference was shown in prevalence of cancer between IRIB elderly patients and the other groups of cancer patients in Iran.

Review on the Potential Therapeutic Roles of Nigella sativa in the Treatment of Patients with Cancer: Involvement of Apoptosis - Black cumin and cancer -

  • Mollazadeh, Hamid;Afshari, Amir R.;Hosseinzadeh, Hossein
    • 대한약침학회지
    • /
    • 제20권3호
    • /
    • pp.158-172
    • /
    • 2017
  • Nigella sativa (N. sativa, family Ranunculaceae) is a medicinal plant that has been widely used for centuries throughout the world as a natural remedy. A wide range of chemical compounds found in N. sativa expresses its vast therapeutic effects. Thymoquinone (TQ) is the main component (up to 50%) in the essential oil of N. sativa. Also, pinene (up to 15%), p-cymene (40%), thymohydroquinone (THQ), thymol (THY), and dithymoquinone (DTQ) are other pharmacologically active compounds of its oil. Other terpenoid compounds, such as carvacrol, carvone, 4-terpineol, limonenes, and citronellol, are also found in small quantities in its oil. The main pharmacological characteristics of this plant are immune system stimulatory, anti-inflammatory, hypotensive, hepatoprotective, antioxidant, anti-cancer, hypoglycemic, anti-tussive, milk production, uricosuric, choleretic, anti-fertility, and spasmolytic properties. In this regard, we have searched the scientific databases PubMed, Web of Science, and Google Scholar with keywords of N. sativa, anti-cancer, apoptotic effect, antitumor, antioxidant, and malignancy over the period from 2000 to 2017. The effectiveness of N. sativa against cancer in the blood system, kidneys, lungs, prostate, liver, and breast and on many malignant cell lines has been shown in many studies, but the molecular mechanisms behind that anti-cancer role are still not clearly understood. From among the many effects of N. sativa, including its anti-proliferative effect, cell cycle arrest, apoptosis induction, ROS generation, anti-metastasis/anti-angiogenesis effects, Akt pathway control, modulation of multiple molecular targets, including p53, p73, STAT-3, PTEN, and $PPAR-{\gamma}$, and activation of caspases, the main suggestive anti-cancer mechanisms of N. sativa are its free radical scavenger activity and the preservation of various anti-oxidant enzyme activities, such as glutathione peroxidase, catalase, and glutathione-S-transferase. In this review, we highlight the molecular mechanisms of apoptosis and the anti-cancer effects of N. sativa, with a focus on its molecular targets in apoptosis pathways.

두경부 영역에 발생한 선양낭포암에서의 p53 단백 발현 (P53 Expression in Adenoid Cystic Carcinoma of the Head and Neck)

  • 김광현;성명훈;장근호;조양선
    • 대한기관식도과학회:학술대회논문집
    • /
    • 대한기관식도과학회 1993년도 제27차 학술대회 초록집
    • /
    • pp.84-84
    • /
    • 1993
  • 17번 염색체의 단완에 위치하여 종양의 억제에 관여하는 p53유전자의 돌연변이로 인한 불활성 p53단백의 과도발현이 유방암과 대장암을 비롯한 인체의 여러 암에 있어서 보고되었으며 일부 암에서는 예후인자로서의 가능성이 제시되었다. 저자들은 비교적 완만히 성장하지만 국소재발 및 원격전이가 잦은 두경부 영역의 선양낭포암에 있어서 p53 단백 발현 양상 및 예후 인자로의 가능성을 알아보고자 1982년부터 1991년 사이에 서울대학병원에서 병리조직학적으로 진단받은 환자 중 추적관찰이 가능하였고 병리조직을 얻을 수 있었던 23례에 대해 p53 단백에 대한 단클론항체를 이용하여 면역 조직화학적 염색을 시행하여 다음과 같은 결과를 얻었다. 총 23례 중 p53단백의 양성 발현을 보인 경우는 7fP(34%)이었으며, p53단백의 양성 발현과 국소재발 또는 원격전이와의 사이에 유의한 상관관계는 없었다.

  • PDF

Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer

  • Akter, Hafeza;Yoon, Jung Hwan;Yoo, Young Sook;Kang, Min-Jung
    • Molecules and Cells
    • /
    • 제41권6호
    • /
    • pp.591-602
    • /
    • 2018
  • Gastric cancer is the fifth most common type of malignancy worldwide, and the survival rate of patients with advanced-stage gastric cancer is low, even after receiving chemotherapy. Here, we validated neurotensin receptor 1 (NTSR1) as a potential therapeutic target in gastric cancer. We compared NTSR1 expression levels in sixty different gastric cancer-tissue samples and cells, as well as in other cancer cells (lung, breast, pancreatic, and colon), by assessing NTSR1 expression via semi-quantitative real-time reverse transcription polymerase chain reaction, immunocytochemistry and western blot. Following neurotensin (NT) treatment, we analyzed the expression and activity of matrix metalloproteinase-9 (MMP-9) and further determined the effects on cell migration and invasion via wound-healing and transwell assays. Our results revealed that NTSR1 mRNA levels were higher in gastric cancer tissues than non-cancerous tissues. Both of NTSR1 mRNA levels and expression were higher in gastric cancer cell lines relative to levels observed in other cancer-cell lines. Moreover, NT treatment induced MMP-9 expression and activity in all cancer cell lines, which was significantly decreased following treatment with the NTSR1 antagonist SR48692 or small-interfering RNA targeting NTSR1. Furthermore, NT-mediated metastases was confirmed by observing epithelial-mesenchymal transition markers SNAIL and E-cadherin in gastric cancer cells. NT-mediated invasion and migration of gastric cancer cells were reduced by NTSR1 depletion through the Erk signaling. These findings strongly suggested that NTR1 constitutes a potential therapeutic target for the inhibition of gastric cancer invasion and metastasis.

circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis

  • Kaiyun Qin;Fenghua Zhang;Hongxia Wang;Na Wang;Hongbing Qiu;Xinzhuan Jia;Shan Gong;Zhengmao Zhang
    • BMB Reports
    • /
    • 제56권3호
    • /
    • pp.184-189
    • /
    • 2023
  • Ovarian cancer (OC) is the most common gynecological malignancy worldwide, and chemoresistance occurs in most patients, resulting in treatment failure. A better understanding of the molecular processes underlying drug resistance is crucial for development of efficient therapies to improve OC patient outcomes. Circular RNAs (circRNAs) and ferroptosis play crucial roles in tumorigenesis and resistance to chemotherapy. However, little is known about the role(s) of circRNAs in regulating ferroptosis in OC. To gain insights into cisplatin resistance in OC, we studied the ferroptosis-associated circRNA circSnx12. We evaluated circSnx12 expression in OC cell lines and tissues that were susceptible or resistant to cisplatin using quantitative real-time PCR. We also conducted in vitro and in vivo assays examining the function and mechanism of lnc-LBCSs. Knockdown of circSnx12 rendered cisplatin-resistant OC cells more sensitive to cisplatin in vitro and in vivo by activating ferroptosis, which was at least partially abolished by downregulation of miR-194-5p. Molecular mechanics studies indicate that circSnx12 can be a molecular sponge of miR-194-5p, which targets SLC7A11. According to our findings, circSnx12 ameliorates cisplatin resistance by blocking ferroptosis via a miR-194-5p/SLC7A11 pathway. CircARNT2 may thus serve as an effective therapeutic target for overcoming cisplatin resistance in OC.

Pericardial Window Operation in Oncology Patients: Analysis of Long-Term Survival and Prognostic Factors

  • Sung Min Kim;Jun Ho Lee;Su Ryeun Chung;Kiick Sung;Wook Sung Kim;Yang Hyun Cho
    • Journal of Chest Surgery
    • /
    • 제57권2호
    • /
    • pp.169-177
    • /
    • 2024
  • Background: Pericardial effusion (PE) is a serious condition in cancer patients, primarily arising from malignant dissemination. Pericardial window formation is a surgical intervention for refractory PE. However, the long-term outcomes and factors associated with postoperative survival remain unclear. Methods: We retrospectively analyzed data from 166 oncology patients who underwent pericardial window formation at Samsung Medical Center between 2011 and 2023. We analyzed survival and PE recurrence regarding surgical approach, cancer type, and cytopathological findings. To identify factors associated with survival, we utilized Cox proportional-hazards regression. Results: All patients had tumors documented in accordance with the American Joint Committee on Cancer staging manual, including lung (61.4%), breast (9.6%), gastrointestinal (9.0%), hematologic (3.6%), and other cancers (16.4%). Surgical approaches included mini-thoracotomy (67.5%) and thoracoscopy (32.5%). Postsurgical cytopathology confirmed malignancy in 94 cases (56.6%). Over a median follow-up duration of 50.0 months, 142 deaths and 16 PE recurrences occurred. The 1-year overall and PE recurrence-free survival rates were 31.4% and 28.6%, respectively. One-year survival rates were significantly higher for thoracoscopy recipients (43.7% vs. 25.6%, p=0.031) and patients with negative cytopathology results (45.1% vs. 20.6%, p<0.001). No significant survival difference was observed between lung cancer and other types (p=0.129). Multivariate analysis identified New York Heart Association class, cancer stage, and cytopathology as independent prognostic factors. Conclusion: This series is the largest to date concerning window formation among cancer patients with PE. Patients' long-term survival after surgery was generally unfavorable. However, cases with negative cytopathology or earlier tumor stage demonstrated comparatively high survival rates.

역동적 유방 자기공명 영상 및 확산 강조영상을 이용한 관상피내암종 저평가 수술전 예측 (Preoperative Prediction of Ductal Carcinoma in situ Underestimation of the Breast using Dynamic Contrast Enhanced and Diffusion-weighted Imaging)

  • 박미나;김은경;김민정;문희정
    • Investigative Magnetic Resonance Imaging
    • /
    • 제17권2호
    • /
    • pp.101-109
    • /
    • 2013
  • 목적: 초음파 유도 하 중심부 침생검으로 진단된 2 cm 이상의 관상피내암종 저평가 수술 전 예측에 역동적 유방 자기공명 영상 및 확산강조영상의 역할을 규명하고자 한다. 대상과 방법: 14 gauge침을 이용한 초음파 유도 하 중심부 침생검을 통해 관상피내암종으로 진단된 22명의 환자를 대상으로 하였다. 환자는 조직병리 결과에 의거하여 관상피내암종 저평가 유무에 따라 두 군으로 나뉘었다. 모든 환자에서 역동적 유방 자기공명 영상 및 확산강조영상을 포함한 3 테슬라 유방 자기공명 영상을 획득하였다. 생검으로 확인된 악성 종괴에 대해, 병변의 형태 (종괴 혹은 비종괴), 조영 증강 형태, 조영 증강 최고점, 및 현성 확산 계수를 CADstream 소프트웨어를 이용하여 획득 하였으며, Fisher's exact test및 Mann Whitney test 이용하여 이 항목을 비교, 분석하였다. 결과: 총 22명의 환자 중 8명의 환자가 저평가 군으로 분류되었다. 병변의 형태 및 조영증강 형태는 두 군의 통계학적 차이가 없었다 (P values = 1.000 및 0.613). 조영 증강 최고점의 중앙값은 저평가 군에서 159.5% 로 저평가 되지 않은 군의 133.5% 보다 높았으나 통계학적 유의한 차이를 보이지 않았다 (P value = 0.413). 저평가 군의 현성 확산 계수는 $1.26{\times}10^{-3}mm^2/sec$로 저평가 되지 않은 군의 $1.35{\times}10^{-3}mm^2/sec$ 보다 낮았다 (P value = 0.094). 결론: 현성 확산 계수는 초음파 유도한 중심부 침생검에 의한 관상피내암종 저평가 수술 전 예측에 도움이 될 가능성 있으며 추후 전향적 연구를 통해 이 연구 결과를 확인하는 것이 필요하겠다.

초음파상 복합성 낭성 유방 종괴의 조직 검사 결과에 관한 연구 (The Study for Results of Complex Cystic Breast Masses by Biopsy on Ultrasound)

  • 강혜경;동경래
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제31권2호
    • /
    • pp.129-134
    • /
    • 2008
  • 목 적: 유방 초음파상 복합성 낭성 종괴를 조직 검사한 결과를 바탕으로 그 결과를 분석하여 초음파 검사자에게 적절한 검사 기준을 제시하고자 한다. 대상 및 방법: 2003년 6월 30일부터 2007년 6월 30일까지 4년 동안 C병원에서 조직 검사 및 수술을 통해 병리 조직학적 결과가 확진된 342명의 환자 중 유방 초음파 소견이 복합성 낭종에 해당한다고 판단되는 178명의 병변을 대상으로 하였다. 주위 조직에 대한 평가나 석회화, 혈류의 분포 상태 등은 분석 대상에서 제외하였고 초음파 장비는 GE사의 logic 200을 사용하고, 조직 생검은 core biopsy용 gun (Kimal사, K7/MBD23)을 사용하였다. 결 과: 178명의 조직검사 결과는 FCC (n=56, 31.4%), Fibrosis (n=41, 23.0%), Fibroadenoma (n=20, 11.2%), Epithelial hyperplasia (n=17, 9.6%), Carcinoma (n=15, 8.4%), Fibroadipose (n=8명, 4.5%), Sclerosing adenosis (n=7, 3.9%), Duct ectasia (n=5, 2.8%), Papiloma (n=5, 2.8%), 그 외 Fat necrosis, Hemangioma, abscess, Dystrophic calcification이 각각(n=1, 0.6%)의 결과를 나타내었다. 결 론: 유방 초음파 영상에서 복합성 낭종의 조직 생검 결과는 Carcinoma 8.4%를 제외하고 모두 양성이었으며, 대부분 섬유 낭종의 스펙트럼에 속하는 것을 알 수 있었다. 그러나 비록 이러한 일반 원칙이 많은 환자군이 연구에서 확인되더라도, 본 연1구에서와 같이 매우 충분하지 못하다. 초음파상 명확히 알 수 없는 종괴에 대해서는 조직 검사를 해야 하는 것이 옳지만 그렇지 못한 경우, 3개월 후 재검을 하여야한다고 사료되며 앞으로도 초음파 영상 평가를 체계적으로 숙지하여 세심하고 주의 깊은 검사를 하여야 한다.

  • PDF